The National Science Foundation awarded a $255,961 Small Business Technology Transfer Phase I Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to Rush River Research Corp. The grant aims to develop a low-cost, automated receptacle for rapid point-of-care sterilization of personal protective equipment, such as filtering facepiece respirators, for frontline healthcare workers during the COVID-19 pandemic. Specifically, the company will construct and...
Fathhome, Inc. received a $255,999 Project Grant award from the National Science Foundation on February 15, 2021 to develop an ozone-based field sterilizer for rapid sterilization and reuse of N95 respirators and other personal protective equipment in response to the COVID-19 pandemic. The work is being conducted under the NSF's Technology, Innovation, and Partnerships program (CFDA 47.084), which seeks to advance science and engineering research and innovative solutions to national...
This $255,966 National Science Foundation Technology, Innovation, and Partnerships award to Nano-Product Engineering, LLC will support the development of an antiviral/antimicrobial micropowder for application to personal protective equipment and respiratory equipment surfaces. The award period is from September 15, 2022 through May 31, 2023. The project aims to improve the protective properties of commonly used PPE and respiratory equipment, which typically only provides passive protection and...
Skyhaven Systems, LLC received a $255,998 Project Grant award from the National Science Foundation Division of Industrial Innovation on August 15, 2021 to complete work by January 31, 2022. The grant funds the development of desktop plug-and-play vaporized hydrogen peroxide sterilizers for personal protective equipment as part of the NSF Engineering program (CFDA 47.041). The Engineering program supports innovation, creativity, and excellence in engineering research and education to improve...
The National Science Foundation (NSF) awarded a $997,689 Cooperative Agreement under its NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Omnicyte LLC, a minority-owned small business in Branford, CT. The funding supports the design and production of a next-generation COVID-19 vaccine that addresses weaknesses of current vaccines, such as reduced booster effectiveness, short-lived efficacy, and side effects. The project aims to develop a vaccine candidate with improved...
This $999,940 Cooperative Agreement awarded on March 15, 2024 by the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (TIP) program supports the development and field deployment of Purafide, LLC's plasma-based water treatment technology to address per- and polyfluoroalkyl substances (PFAS) contamination. The project aims to pilot the innovative plasma reactor technology at high-priority PFAS remediation and landfill sites in Michigan, with the goal of achieving PFAS...
The National Science Foundation Division of Industrial Innovation awarded a $256,000 Project Grant to Avior Inc., doing business as Avior Bio, to develop a safe and effective copper nanoparticle suspension formulation for face mask applications against SARS-CoV-2 and other viruses. The grant period runs from July 1, 2021 through December 31, 2021 under the Engineering (47.041) federal grant program. Through this funding, Avior Bio will work to produce a nanoparticle formulation that can be...
This National Science Foundation (NSF) Cooperative Agreement award (CFDA 47.084) provides $995,600 in funding to Purebiox, Inc., a small disadvantaged business based in St. Paul, Minnesota, to develop an end-to-end solution for high-volume water microbiological testing. The project aims to enhance public health and safety by enabling early detection of waterborne viruses such as SARS-CoV-2 and norovirus, potentially weeks before outbreaks occur. The innovative platform integrates a novel...
This $249,999 National Science Foundation project grant supports the development of a bioengineered nanobarrier spray to protect against SARS-CoV-2 and other viral infections of the nasopharynx. Funded under the NSF Engineering program (CFDA 47.041), the two-year award to the University of Southern California will support computational modeling of nanobarrier delivery via nasal applicator as well as efficacy testing in a coronavirus mouse model. Specifically, the university researchers will...
The National Institute of Standards and Technology awarded Vuronyx Technologies LLC a $1,599,940.60 cooperative agreement under the Science, Technology, Business and/or Education Outreach program (CFDA 11.620) to develop acetylperoxyborate (APB) powders for disinfecting personal protective equipment. Vuronyx will perform efficacy testing of APB powders against viruses on test coupons and evaluate resulting byproducts and residues. It will also evaluate the structural integrity of N95 masks and...
The National Science Foundation (NSF) awarded a $878,296 Cooperative Agreement to Surfplasma Inc., a minority-owned small business based in Gainesville, FL, to develop a rapid, low-temperature plasma prototype for disinfecting personal protective equipment (PPE), medical devices, food products and other materials from pathogens like COVID-19. The project, funded under NSF's Technology, Innovation, and Partnerships (CFDA 47.084) program, aims to deliver a market-ready sterilization solution with proven efficacy, optimized cycle times, and a user-friendly control system. Key objectives include conducting efficacy tests against Biosafety Level 2 and 3 pathogens, optimizing the ozone removal system, and ensuring material compatibility. Successful completion of this 2-year project will result in a prototype that can be commercialized to help prevent hospital-acquired infections and mitigate the spread of COVID-19 and future outbreaks in crowded facilities and community settings.